Hedgehog signaling maintains chemoresistance in myeloid leukemic cells

Oncogene

Volumn 29, Issue 48, 2010, Pages 6314-6322

  Queiroz, K C S ^a,b,c   Ruela De Sousa, R R ^a,b   Fuhler, G M ^b   Aberson, H L ^c   Ferreira, C V ^a   Peppelenbosch, M P ^b   Spek, C A ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Hedgehog; leukemia; multidrug resistance; P glycoprotein

Indexed keywords

COLECALCIFEROL; CYCLOPAMINE; DOXORUBICIN; GLYCOPROTEIN P; MITOXANTRONE; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CHEMOSENSITIVITY; HEDGEHOG; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HEDGEHOG PROTEINS; HUMANS; LEUKEMIA, MYELOID; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 78649849508     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.375     Document Type: Article

References (22)

1. Bijlsma MF, Spek CA, Zivkovic D, Van de Water S, Rezaee F, Peppelenbosch MP. (2006). Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol 4: e232.
2. Chen JK, Taipale J, Cooper MK, Beachy PA. (2002). Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smooth-ened. Genes Dev 16: 2743-2748.
3. Dean M. (1997). Towards a unified model of tumor suppression: lessons learned from the human patched gene. Biochim Biophys Acta 1332: 43-52.
4. Dean M, Fojo T, Bates S. (2005). Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
5. Diehl KM, Keller ET, Ignatoski KM. (2007). Why should we still care about oncogenes? Mol Cancer Ther 6: 418-427.
6. Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al. (2008). Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14: 238-249.
7. Hartree EF. (1972). Determination of proteins: a modification of Lowry method that give a linear photometric response. Anal Biochem 48: 422-427.
8. Higgins CF. (2007). Multiple molecular mechanisms for multidrug resistance transporters. Nature 446: 749-757.
9. Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH et al. (2009). Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 4: 559-567.
10. Kobune M, Takimoto R, Murase K, Iyama S, Sato T, Kikuchi S et al. (2009). Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells. Cancer Sci 100: 948-955.
11. Kroemer G, Pouyssegur J. (2008). Tumor cell metabolism: cancer's achilles' heel. Cancer Cell 13: 472-482.
12. Lauth M, Bergstrom A, Shimokawa T, Toftgard R. (2007). Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci USA 104: 8455-8460.
13. Lauth M, Toftgard R. (2007). The Hedgehog pathway as a drug target in cancer therapy. Curr Opin Investig Drugs 8: 457-461.
14. Lowenberg B. (2007). On the road to new drugs in acute myeloid leukemia. JCO 25: 1-2.
15. Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L et al. (2003). A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia 17: 1794-1805.
16. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 65: 55-63.
17. O'Hare T, Corbin AS, Druker BJ. (2006). Targeted CML therapy: controlling drug resistance, seeking cure. Curr Opin Genet Dev 16: 92-99.
18. Rumjanek VM, Trindade GS, Wagner-Souza K, de-Oliveira MC, Marques-Santos LF, Maia RC et al. (2001). Multidrug resistance in tumor cells: characterisation of the multidrug resistant cell line K562-Lucena 1. Ann Acad Bras Ci 73: 57-69.
19. Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R et al. (2006). Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12: 6565-6572.
20. Svard J, Heby-Henricson K, Persson-Lek M, Rozell B, Lauth M, Bergstrom A et al. (2006). Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev Cell 10: 187-197.
21. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. (2009). Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458: 776-779.
22. Zhao Y, Tong C, Jiang J. (2007). Hedgehog regulates smoothened activity by inducing a conformational switch. Nature 450: 252-258.